Publicación:
Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
No hay miniatura disponible
Fecha
2015
Autores
Mezones-Holguin E.
Canelo-Aybar C.
Clark A.D.
Janusz C.B.
Jaúregui B.
Escobedo-Palza S.
Hernandez A.V.
Vega-Porras D.
González M.
Fiestas F.
Título de la revista
Revista ISSN
Título del volumen
Editor
Elsevier Ltd
Proyectos de investigación
Unidades organizativas
Número de la revista
Abstracto
Descripción
This study was made possible through the financial support of the Instituto Nacional de Salud (National Institute of Health, Lima, Peru) and the PROVAC Initiative of the Pan American Health Organization (Washington, DC, USA). This study was presented at 9th International Symposium of Pneumococci and Pneumococcal Diseases, Hyderabad, India, March 2014, and supported by the National Council of Science, Technology and Technological Innovation of Peru (CONCYTEC) and International Clinical Epidemiology Network (INCLEN Trust).
Palabras clave
Pneumococcus vaccine,
10-valent pneumococcal conjugate vaccine,
13-valent pneumococcal vaccine,
acute otitis media